134 related articles for article (PubMed ID: 36744537)
1. Drugs swapping in coronavirus strains: a structural biology view.
Gurjar V; Iqra Kamil S; Chandra A; Qamar I; Singh N
J Biomol Struct Dyn; 2023; 41(22):13488-13495. PubMed ID: 36744537
[TBL] [Abstract][Full Text] [Related]
2. Corona virus versus existence of human on the earth: A computational and biophysical approach.
Zehra Z; Luthra M; Siddiqui SM; Shamsi A; Gaur NA; Islam A
Int J Biol Macromol; 2020 Oct; 161():271-281. PubMed ID: 32512089
[TBL] [Abstract][Full Text] [Related]
3. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight.
Khan MI; Khan ZA; Baig MH; Ahmad I; Farouk AE; Song YG; Dong JJ
PLoS One; 2020; 15(9):e0238344. PubMed ID: 32881907
[TBL] [Abstract][Full Text] [Related]
4. Properties of Coronavirus and SARS-CoV-2.
Malik YA
Malays J Pathol; 2020 Apr; 42(1):3-11. PubMed ID: 32342926
[TBL] [Abstract][Full Text] [Related]
5. Current Strategies of Antiviral Drug Discovery for COVID-19.
Mei M; Tan X
Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
[TBL] [Abstract][Full Text] [Related]
6. Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19.
Yadav R; Chaudhary JK; Jain N; Chaudhary PK; Khanra S; Dhamija P; Sharma A; Kumar A; Handu S
Cells; 2021 Apr; 10(4):. PubMed ID: 33917481
[TBL] [Abstract][Full Text] [Related]
7. In silico characterization of mutations circulating in SARS-CoV-2 structural proteins.
Periwal N; Rathod SB; Pal R; Sharma P; Nebhnani L; Barnwal RP; Arora P; Srivastava KR; Sood V
J Biomol Struct Dyn; 2022 Nov; 40(18):8216-8231. PubMed ID: 33797336
[TBL] [Abstract][Full Text] [Related]
8. An insight into SARS-CoV-2 membrane protein interaction with spike, envelope, and nucleocapsid proteins.
Kumar P; Kumar A; Garg N; Giri R
J Biomol Struct Dyn; 2023 Feb; 41(3):1062-1071. PubMed ID: 34913847
[TBL] [Abstract][Full Text] [Related]
9. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of
Basu BV; Brown OR
Front Biosci (Landmark Ed); 2020 Jun; 25(10):1894-1900. PubMed ID: 32472763
[TBL] [Abstract][Full Text] [Related]
11. Structural Proteins in Severe Acute Respiratory Syndrome Coronavirus-2.
Satarker S; Nampoothiri M
Arch Med Res; 2020 Aug; 51(6):482-491. PubMed ID: 32493627
[TBL] [Abstract][Full Text] [Related]
12. Potential drug targets of SARS-CoV-2: From genomics to therapeutics.
Shamsi A; Mohammad T; Anwar S; Amani S; Khan MS; Husain FM; Rehman MT; Islam A; Hassan MI
Int J Biol Macromol; 2021 Apr; 177():1-9. PubMed ID: 33577820
[TBL] [Abstract][Full Text] [Related]
13. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
14. RNAi-mediated siRNA sequences to combat the COVID-19 pandemic with the inhibition of SARS-CoV2.
Saadat KASM
Gene Rep; 2022 Mar; 26():101512. PubMed ID: 35071824
[TBL] [Abstract][Full Text] [Related]
15. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
Troyano-Hernáez P; Reinosa R; Holguín Á
Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern.
Hawman DW; Meade-White K; Archer J; Leventhal SS; Wilson D; Shaia C; Randall S; Khandhar AP; Krieger K; Hsiang TY; Gale M; Berglund P; Fuller DH; Feldmann H; Erasmus JH
Elife; 2022 Feb; 11():. PubMed ID: 35191378
[TBL] [Abstract][Full Text] [Related]
17. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target.
Kundu D; Selvaraj C; Singh SK; Dubey VK
J Biomol Struct Dyn; 2021 Jun; 39(9):3428-3434. PubMed ID: 32362243
[TBL] [Abstract][Full Text] [Related]
18. A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV).
Dong S; Sun J; Mao Z; Wang L; Lu YL; Li J
J Med Virol; 2020 Sep; 92(9):1542-1548. PubMed ID: 32181901
[TBL] [Abstract][Full Text] [Related]
19. Structural Genomics of SARS-CoV-2 Indicates Evolutionary Conserved Functional Regions of Viral Proteins.
Srinivasan S; Cui H; Gao Z; Liu M; Lu S; Mkandawire W; Narykov O; Sun M; Korkin D
Viruses; 2020 Mar; 12(4):. PubMed ID: 32218151
[TBL] [Abstract][Full Text] [Related]
20. Minireview of progress in the structural study of SARS-CoV-2 proteins.
Zhu G; Zhu C; Zhu Y; Sun F
Curr Res Microb Sci; 2020 Sep; 1():53-61. PubMed ID: 33236001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
